Vertex Pharmaceuticals executive reports no VRTX stake
Vertex Pharmaceuticals reported Jasper van Grunsven, EVP, CP and NPPO, as an insider with no reportable holdings or transactions on his initial Form 3.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
3
Rhea-AI Filing Summary
VERTEX PHARMACEUTICALS INC / MA (VRTX) filed an initial statement of beneficial ownership for Jasper van Grunsven, who serves as EVP, CP and NPPO. The Form 3 lists no reportable holdings or transactions in Vertex securities at the time of this filing. A Power of Attorney is noted as Exhibit 24.
Key Figures
Buy transactions: 0
Sell transactions: 0
Derivative positions: 0
+1 more
4 metrics
Buy transactions
0
Number of buy transactions reported for this Form 3
Sell transactions
0
Number of sell transactions reported for this Form 3
Derivative positions
0
Number of derivative transaction records and remaining derivative positions
Holding entries
0
Reported holding entries in non-derivative securities
Key Terms
Form 3, beneficial ownership, Power of Attorney, derivative positions
4 terms
Form 3 regulatory
"filed an initial statement of beneficial ownership for Jasper van Grunsven"
Form 3 is the initial public filing that officers, directors and large shareholders must submit to report their ownership of a company’s securities when they become insiders. It acts like an opening inventory sheet that gives investors a starting point to see who holds significant stakes and to spot later trades or potential conflicts of interest, helping assess insider confidence and transparency.
beneficial ownership financial
"filed an initial statement of beneficial ownership for Jasper van Grunsven"
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.
Power of Attorney regulatory
"A Power of Attorney is noted as Exhibit 24"
A power of attorney is a legal document that allows one person to make decisions and act on behalf of another person, often in financial or legal matters. It’s like giving someone a trusted helper or agent the authority to handle important tasks if you are unable to do so yourself. This matters to investors because it can impact how their assets are managed or transferred if they become unable to oversee their affairs.
derivative positions financial
"no derivative positions, indicating that no beneficial ownership"
Derivative positions are contracts that derive their value from an underlying asset—such as a stock, bond, currency or commodity—and include instruments like options, futures and swaps. Think of them as bets or insurance tied to an asset’s future price: they let investors amplify returns, hedge risk or take exposure without owning the asset directly, which can meaningfully increase potential gains, losses and volatility in a portfolio.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does the Form 3 filing for VRTX disclose about Jasper van Grunsven?
The Form 3 identifies Jasper van Grunsven as an insider of Vertex Pharmaceuticals, serving as EVP, CP and NPPO. It reports no transactions and no reportable holdings of Vertex securities at the time of the filing.
Are there any buy or sell transactions reported for VRTX in this Form 3?
No. The Form 3 for VRTX shows no buy or sell transactions, with all transaction-related counts, including buys, sells, exercises, and gifts, reported as zero in the transaction summary.
What position does Jasper van Grunsven hold at Vertex Pharmaceuticals (VRTX)?
Jasper van Grunsven is reported as an officer of Vertex Pharmaceuticals with the title EVP, CP and NPPO, as disclosed in the reporting person details of the Form 3.
What additional document is referenced in this VRTX Form 3 filing?
The remarks section references Exhibit 24 - Power of Attorney, indicating that a power of attorney document is associated with this Form 3 for Vertex Pharmaceuticals.
AI-generated analysis. How Rhea-AI works. Not financial advice.
